February 16, 2017 / 12:19 PM / 9 months ago

Pharma group Shire posts earnings rise at top of guidance

LONDON, Feb 16 (Reuters) - Pharmaceuticals group Shire reported a 12 percent rise in full-year earnings after what it said was a transformational year marked by its largest acquisition to date, adding that it is extremely optimistic on long-term growth prospects.

The London-listed company posted non-GAAP diluted earnings per share of $13.10 on Thursday, right at the top of its guidance, on revenue up 78 percent to $11.4 billion. (Reporting by Paul Sandle; Editing by David Goodman)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below